Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies - ScienceDirect

Biomedicines, Free Full-Text

Inflammatory bowel disease: symptoms and diagnosis - The Pharmaceutical Journal

Advances in the treatment of Crohn's disease and ulcerative

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study - ScienceDirect

Anyone heard of drug called 'FT 28'???

Compounding for Crohn's Disease & Ulcerative Colitis - Town & Country Compounding

Weighing the new approaches to treating Crohn's and ulcerative colitis - Harvard Health

Advances in diagnostics, treatments, and frontiers of research in IBD